SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 6, 2006, Pages 1070-1076

  Gould, Virginia C ^a   Avison, Matthew B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Efflux pumps; Nosocomial infections; SmeT

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARRIER PROTEIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENE PRODUCT; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; MULTIDRUG RESISTANCE PROTEIN; SMED PROTEIN; SMEE PROTEIN; SMEF PROTEIN; SMET PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIAL RNA; MESSENGER RNA; REPRESSOR PROTEIN; SMED PROTEIN, STENOTROPHOMONAS MALTOPHILIA; SMEE PROTEIN, STENOTROPHOMONAS MALTOPHILIA; SMEF PROTEIN, STENOTROPHOMONAS MALTOPHILIA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BINDING SITE; CHROMOSOME MUTATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INSERTION; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; MULTIDRUG RESISTANCE; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPIC VARIATION; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STENOTROPHOMONAS MALTOPHILIA; DRUG EFFECT; GENETICS; GRAM NEGATIVE INFECTION; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION; PHYSIOLOGY; REGULATOR GENE; TRANSPOSON;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, REGULATOR; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, INSERTIONAL; MUTATION; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, MESSENGER; STENOTROPHOMONAS MALTOPHILIA;

EID: 33749174766     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl106     Document Type: Article

References (25)

1. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11: 57-80.
2. Senol E. Stenotrophomonas maltophilia: The significance and role as a nosocomial pathogen. J Hosp Infect 2004; 57: 1-7.
3. Avison MB, Higgins CS, von Heldreich CJ et al. Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45: 413-9.
4. Avison MB, Higgins CS, Ford PJ et al. Differential regulation of L1 and L2 β-lactamase expression in Stenotrophomonas maltophilia. J Antimicrob Chemother 2002; 49: 387-9.
5. Lambert T, Ploy MC, Denis F et al. Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1999; 43: 2366-71.
6. Li X-Z, Zhang L, McKay GA et al. Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimicrob Chemother 2003; 51: 803-11.
7. Okazaki A, Avison MB. Characterization of the Aph(3′)-IIa determinant of Stenotrophomonas maltophilia, In: Abstracts of the Forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004. Abstract C1-1497, p. 85, American Society for Microbiology, Washington, DC, USA.
8. Alonso A, Sanchez P, Martinez JL. Stenotrophomonas maltophilia D457R contains a cluster of genes from Gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother 2000;44:1778-82.
9. Barbolla R, Catalano M, Orman BE et al. Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother 2004; 48:666-9.
10. Li X-Z, Zhang L, Poole K. SmeC an outer membrane multi-drug efflux protein of stenotrophomonas maltophilla. Antimicrob Agents Chemother 2002; 46: 333-43.
11. Alonso A, Martinez JL. Cloning and characterization of SmeDEF, a novel multi-drug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2000; 44: 3079-86.
12. Sanchez P, Alonso A, Martinez JL. Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multi-drug efflux pump SmeDEF. Antimicrob Agents Chemotherapy 2002; 46: 3386-93.
13. Berg G, Roskot N, Smalla K. Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol 1999; 37: 3594-600.
14. Valdezate S, Vindel A, Martin-Davila P et al. High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004; 42: 693-9.
15. Gould VC, Okazaki A, Howe RA et al. Analysis of sequence variation amongst smeDEF multi-drug efflux pump genes and flanking DNA from defined 16S rRNA sub-groups of clinical Stenotrophomonas maltophilia isolates. J Antimicrob Chemother 2004; 54: 348-53.
16. Gould VC, Okazaki A, Avison MB. β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J Antimicrob Chemother 2006; 57: 199-203.
17. Zhang L, Li X-Z, Poole K. SmeDEF multi-drug efflux pump contributes to intrinsic multi-drug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45: 3497-503.
18. Avison MB, von Heldreich CJ, Higgins CS et al. A TEM-2 β-lactamase encoded on an active Tn 1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother 2000; 46: 879-84.
19. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ et al. Abroad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: Application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 1998; 212: 77-86.
20. Valdezate S, Vindel A, Echeita A et al. Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother 2002; 46: 665-71.
21. Sanchez P, Alonso A, Martinez JL. Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of multidrug efflux pump SmeDEF. Antimicrob Agents Chemother 2004:48:2274-6.
22. Cao L, Srikumar R, Poole K. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: Identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol Microbiol 2004; 53: 1423-36.
23. Masuda N, Sakagawa E, Ohya S et al. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000; 44: 2242-6.
24. Reddy BR, Shaw LE, Sayers JR et al. Two identical copies of IS 1246, a 1275 base pair sequence related to other bacterial insertion sequences, enclose the xy/genes on TOL plasmid pWWO. Microbiology 1994; 140:2305-7.
25. Olliver A. Valle M, Chaslus-Dancla E et al. Overexprcssion of the multidrug efflux operon acrEF by insertional activation with IS1 of IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob Agents Chemother 2005; 49:289-301.